Insider Trading Alert - OHI, DAL And ANF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 2, 2014, 92 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $256.46 to $6,915,950.00.

Highlighted Stocks Traded by Insiders:

Omega Healthcare Investors (OHI) - FREE Research Report

Pickett C Taylor, who is Chief Executive Officer at Omega Healthcare Investors, sold 30,000 shares at $37.00 on June 2, 2014. Following this transaction, the Chief Executive Officer owned 272,849 shares meaning that the stake was reduced by 9.91% with the 30,000-share transaction.

Stephenson Robert O, who is Chief Financial Officer at Omega Healthcare Investors, sold 2,500 shares at $37.00 on June 2, 2014. Following this transaction, the Chief Financial Officer owned 157,471 shares meaning that the stake was reduced by 1.56% with the 2,500-share transaction.

The shares most recently traded at $36.93, down $0.07, or 0.19% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 4-Week # shares bought: 32,424
  • 4-Week # shares sold: 17,500
  • 12-Week # shares bought: 32,424
  • 12-Week # shares sold: 40,000
  • 24-Week # shares bought: 32,424
  • 24-Week # shares sold: 40,000

The average volume for Omega Healthcare Investors has been 1.1 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $4.6 billion and is part of the financial sector and real estate industry. Shares are up 24.36% year-to-date as of the close of trading on Monday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 5.42%. The company has a P/E ratio of 23.5. Currently, there is 1 analyst who rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Delta Air Lines (DAL) - FREE Research Report

Easter William H Iii, who is Director at Delta Air Lines, bought 2,000 shares at $39.75 on June 2, 2014. Following this transaction, the Director owned 26,120 shares meaning that the stake was boosted by 8.29% with the 2,000-share transaction.

The shares most recently traded at $41.16, up $1.41, or 3.43% since the insider transaction. Historical insider transactions for Delta Air Lines go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 100,927
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 100,927
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 263,023

The average volume for Delta Air Lines has been 11.3 million shares per day over the past 30 days. Delta Air Lines has a market cap of $33.8 billion and is part of the services sector and transportation industry. Shares are up 48.42% year-to-date as of the close of trading on Monday.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo worldwide. Its route network comprises various gateway airports in Amsterdam, Atlanta, Cincinnati, Detroit, Memphis, Minneapolis-St. The stock currently has a dividend yield of 0.6%. The company has a P/E ratio of 3.2. Currently, there are 11 analysts who rate Delta Air Lines a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DAL - FREE

TheStreet Quant Ratings rates Delta Air Lines as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, reasonable valuation levels, solid stock price performance, compelling growth in net income and revenue growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Delta Air Lines Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Abercrombie & Fitch (ANF) - FREE Research Report

Stapleton Craig R, who is Director at Abercrombie & Fitch, bought 10,000 shares at $37.30 on June 2, 2014. Following this transaction, the Director owned 37,398 shares meaning that the stake was boosted by 36.5% with the 10,000-share transaction.

The shares most recently traded at $38.43, up $1.13, or 2.94% since the insider transaction. Historical insider transactions for Abercrombie & Fitch go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 50,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 155,681
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 205,681

The average volume for Abercrombie & Fitch has been 2.2 million shares per day over the past 30 days. Abercrombie & Fitch has a market cap of $2.8 billion and is part of the services sector and retail industry. Shares are up 17.17% year-to-date as of the close of trading on Monday.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel for men, women, and kids. It operates through three segments: U.S. Stores, International Stores, and Direct-to-Consumer. The stock currently has a dividend yield of 2.1%. The company has a P/E ratio of 40.4. Currently, there are 12 analysts who rate Abercrombie & Fitch a buy, 2 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ANF - FREE

TheStreet Quant Ratings rates Abercrombie & Fitch as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Abercrombie & Fitch Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?